v2.4.0.6
Consolidated Condensed Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 31, 2011
Dec. 25, 2010
Dec. 31, 2011
Dec. 25, 2010
Consolidated Condensed Statements Of Operations [Abstract]        
Net sales $ 122,368 $ 95,625 $ 316,212 $ 278,138
Cost of sales 56,338 43,163 148,118 122,161
Gross margin 66,030 52,462 168,094 155,977
Operating expenses:        
Research and development 23,143 16,348 61,592 46,890
Selling, general and administrative 16,488 13,431 47,854 42,814
Restructuring and other costs, net   (395)   6
Impairment of non-marketable securities       500
Provision for litigation expenses and settlements   (30)   105
Patent agreement, net       (4,000)
Total operating expenses 39,631 29,354 109,446 86,315
Income from operations 26,399 23,108 58,648 69,662
Interest income, net 112 212 378 673
Other income (expense), net (71) (31) (115) (13)
Income before income taxes 26,440 23,289 58,911 70,322
Provision (benefit) for income taxes 9,709 (1,332) 21,755 (2,775)
Net income $ 16,731 $ 24,621 $ 37,156 $ 73,097
Basic income per share: $ 0.26 $ 0.36 $ 0.57 $ 1.08
Diluted income per share: $ 0.25 $ 0.34 $ 0.55 $ 1.02
Basic weighted average common shares outstanding: 63,957 68,074 65,161 67,731
Diluted weighted average common shares outstanding: 66,989 71,695 68,099 71,868